Investor and analyst presentation Full Year Results 2012 Date/Time: Tuesday, 19 February 2013, 10.00 am - 11.30 am CET Location: SIX Swiss Exchange, ConventionPoint, Auditorium, Selnaustrasse 30, Zurich, Switzerland RSVP: Patricia Dal Pont, +41 43 211 42 14, email@example.com This presentation will be audio-webcast live at www.nobelbiocare.com/investors and is also accessible via telephone conference. For the telephone conference, please dial in 10-15 minutes prior to the scheduled start using the following numbers (live-access to speakers for questions after the presentation): +41 91 610 56 00 Continental Europe +44 203 059 58 62 UK +1 631 570 56 13 USA For additional local dial-in numbers please refer to the separate list attached or available on our website. Recording of the webcast will be available on the website shortly after the end of the conference. The Full Year Results 2012 of Nobel Biocare will be published on 19 February 2013, at around 6.45 am CET. As Nobel Biocare is covered by various financial analysts, the company has contracted Vara Research to periodically update the consensus analysis, based on the estimates of all participating brokerage firms. The most recent analyst consensus can be accessed at any time via the following site: http://corporate.nobelbiocare.com/en/investors/financial-analysis/analyst-consensus.aspx. Nobel Biocare Holding AG Süha Demokan VP Investor & Corporate Relations Save the date 15 March 2013, 9 am CET - Investor and analyst breakout session at the IDS in Cologne in Germany Kloten, 5 February, 2013 Invitation (PDF) Additional dial-in numbers (PDF) Provider Channel Contact Tensid Ltd., Switzerland newsbox.ch Provider/Channel related enquiries www.tensid.ch www.newsbox.ch firstname.lastname@example.org +41 41 763 00 50
Invitation to Full Year 2012 results publication on 19 February
Press spacebar to pause and continue. Press esc to stop.